Resources Contact Us Home
Modified leukotoxin protein

Image Number 10 for United States Patent #7790170.

The present invention provides nucleic acid sequences encoding a modified leukotoxin protein, wherein the modification comprises the removal of nucleic acid sequences encoding amino acids within hydrophobic transmembrane domains of full length leukotoxin protein, preferably from Mannheimia haemolytica. The modified leukotoxin proteins are useful in vaccine compositions effective against Mannheimia haemolytica in animals.

  Recently Added Patents
Requirements model comparative analysis method for effort estimation in customizing a network monitoring and control system
Bessel beam plane illumination microscope
System and method to obtain signal acquisition assistance data
Efficient paging in a wireless communication system
Fuser member having composite outer layer
Upstream channel bonding in a cable communications system
  Randomly Featured Patents
Manufacturing method of electrophoretic display sheet, manufacturing method of electrophoretic display device, electrophoretic display device, and electronic apparatus
Method for reduction of pollution from combustion chambers
Pressure compacting of settable plaster compositions
Voting machine
Anti-atherosclerotic peptides and a transgenic mouse model of antherosclerosis
System and method of image zooming with intensity preservation
Intermodulation product stabilized laser
Single-mode optical fiber
Retortable composite closure for plastic containers
High conductivity launder resistant grounding tape